 CAMBRIDGE, Mass.--BUSINESS WIRE--Tango Therapeutics, Inc. NASDAQ: TNGX, a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that five abstracts have been selected for presentation as virtual posters at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics on October 7 10, 2021. The preclinical data being presented today highlight the potential applicability of synthetic letha 